UnknownPhase 4NCT02920593
A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy
Studying HELLP syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Stony Brook University
- Principal Investigator
- Diana J Garretto, MDSUNY Stony Brook Hospital
- Intervention
- Vitamin D3(drug)
- Enrollment
- 412 enrolled
- Eligibility
- 18 years · FEMALE
- Timeline
- 2016 – 2019
Study locations (1)
- SUNY Stony Brook Hospital, Stony Brook, New York, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02920593 on ClinicalTrials.govOther trials for HELLP syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07151339Pilot Project Renal and Cardiovascular Tertiary Prevention in PreeclampsiaUniversity Hospital Schleswig-Holstein
- RECRUITINGNCT05500989PlacEntal Acute Atherosis RefLecting Subclinical AtherosclerosisMaastricht University Medical Center
- RECRUITINGNCT06377878The Preeclampsia RegistryPreeclampsia Foundation